Table 1 Patients characteristics
From: Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis
| Â | All patients (n = 121) |
|---|---|
Age (years) | 73 ± 7.3 |
Body weight (kg) | 81.0 ± 13.7 |
Time since diagnosis of prostate cancer (years) | 7 ± 11 |
Gleason score at diagnosisa | |
 < 8 | 38 (36%) |
 ≥ 8 | 69 (64%) |
PSA at the time of PET/CT imaging (ng/ml) | 114 ± 671 |
Prior lines of systemic treatment | |
 2 | 8 (7%) |
 ≥ 3 | 113 (93%) |
 ≥ 4 | 78 (64%) |
 ≥ 5 | 44 (36%) |
 ≥6 | 25 (21%) |
Sites of disease on PSMA-PET | |
 Bone | 112 (93%) |
 Lymph nodes | 97 (80%) |
 Visceralb | 43 (36%) |
 Bone + lymph nodes | 88 (73%) |
 Bone + lymph nodes + visceral | 34 (28%) |